1978
New Anticancer Drugs
Muggia F, Bono V, DeVita V. New Anticancer Drugs. Antibiotics And Chemotherapy 1978, 23: 42-49. PMID: 646328, DOI: 10.1159/000401470.Peer-Reviewed Original Research
1972
Clinical study with bleomycin: Tolerance to twice weekly dosage
Ohnuma T, Selawry O, Holland J, DeVita V, Shedd D, Hansen H, Muggia F. Clinical study with bleomycin: Tolerance to twice weekly dosage. Cancer 1972, 30: 914-922. PMID: 4116909, DOI: 10.1002/1097-0142(197210)30:4<914::aid-cncr2820300409>3.0.co;2-8.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAntibiotics, AntineoplasticBleomycinCarcinoma, Squamous CellFemaleHead and Neck NeoplasmsHumansLymphoma, Non-HodgkinMaleMiddle AgedSkin NeoplasmsTesticular NeoplasmsConceptsSquamous cell carcinomaCell carcinomaDose levelsObjective tumor responseBody surface areaTherapeutic dose levelsOptimal dose levelNew antineoplastic agentsPulmonary infiltratesTransient hypertensionUrinary burningAbdominal distentionComplete remissionHematologic toxicityCutaneous toxicityWeekly dosesProlonged courseAdditional patientsPatient toleranceSkin toxicityMalignant neoplasmsTesticular carcinomaTumor responseTumor regressionWeekly dosage
1968
Antitumor activity and some pharmacologic properties of anthramycin methyl ether.
Adamson R, Hart L, DeVita V, Oliverio V. Antitumor activity and some pharmacologic properties of anthramycin methyl ether. Cancer Research 1968, 28: 343-7. PMID: 5641523.Peer-Reviewed Original Research